Pricing

Adynxx Inc (ADYX)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
David Ian Johnson
Employees:
6
100 PINE ST., STE. 500, SAN FRANCISCO, CA, 94111
(415) 512-7740

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • ALLIQUA BIOMEDICAL, INC.(DE) COMMON
Stock Split History
DateRatio
2001-08-01 4:1
2013-11-19 100:4375
2017-10-06 1:10
2019-05-06 1:6
Adynxx, Inc. focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. The company was founded in 2007 and is headquartered in San Francisco, California.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available